(Q28852343)

27 February 2017

290.11 dalton

1 reference

PubChem

chemical formula

C₅H₁₂N₂O₈P₂

0 references

canonical SMILES

O.O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O

1 reference

1 reference

EMEA/H/C/000595

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000595/human_med_000622.jsp

22 March 2017

Zoledronic Acid Accord

1 reference

EMEA/H/C/002667

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002667/human_med_001722.jsp

22 March 2017

Zoledronic Acid Actavis

1 reference

EMEA/H/C/002488

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002488/human_med_001557.jsp

22 March 2017

Zoledronic Acid Hospira

1 reference

EMEA/H/C/002365

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002365/human_med_001601.jsp

22 March 2017

Zoledronic Acid Medac

1 reference

EMEA/H/C/002359

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002359/human_med_001577.jsp

22 March 2017

Zoledronic Acid Mylan

1 reference

EMEA/H/C/002482

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002482/human_med_001585.jsp

22 March 2017

Zoledronic Acid Teva

1 reference

EMEA/H/C/002439

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002439/human_med_001562.jsp

Zoledronic Acid Teva Generics

22 March 2017

1 reference

EMEA/H/C/002805

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002805/human_med_001743.jsp

Zoledronic Acid Teva Pharma

22 March 2017

1 reference

EMEA/H/C/002437

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002437/human_med_001563.jsp

22 March 2017

1 reference

14 February 2018

1 reference

14 February 2018

medical condition treated

postmenopausal osteoporosis

1 reference

2 October 2018

renal cell carcinoma

1 reference

2 October 2018

osteoporosis

1 reference

2 October 2018

bone disease

1 reference

2 October 2018

kidney cancer

1 reference

2 October 2018

hypercalcemia

1 reference

bone density conservation agents

2 October 2018

subject has role

1 reference

Medical Subject Headings

15 March 2018

C1699

1 reference

InChI=1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2

27 February 2017

UNII

6XC1PAD3KF

Identifiers

InChI

0 references

InChIKey

FUXFIVRTGHOMSO-UHFFFAOYSA-N

0 references

CAS Registry Number

165800-06-6

1 reference

DSSTOX compound identifier

27 February 2017

0 references

1 reference

0 references

DTXCID2090520

0 references

EC number

641-365-1

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.169.159

ECHA Substance Infocard ID

27 December 2018

title

[1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid hydrate (English)

quotation

CAS no.: 165800-06-6 (English)

100.169.159

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.169.159

27 December 2018

title

[1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid hydrate (English)

quotation

CAS no.: 165800-06-6 (English)

MeSH descriptor ID

C088658

1 reference

27 February 2017

1 reference

27 February 2017

1 reference